The effect of clozapine on extracellular dopamine levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration: Comparison with a selective 5-HT2C receptor antagonist

Neuropsychopharmacology

Volumn 30, Issue 2, 2005, Pages 372-380

  Shilliam, Claire S ^a   Dawson, Lee A ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT2C receptors; Clozapine; Dopamine; Microdialysis; Nucleus accumbens

Indexed keywords

5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL] 6 TRIFLUOROMETHYLINDOLINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ACUTE DRUG ADMINISTRATION; AMINE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; INTERMETHOD COMPARISON; MALE; MICRODIALYSIS; MORPHOLOGICAL ADAPTATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOZAPINE; DOPAMINE; ELECTROCHEMISTRY; EXTRACELLULAR SPACE; INDOLES; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN ANTAGONISTS;

EID: 12344262729     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300591     Document Type: Article

References (47)

1. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18: 63-101.
2. Ashby Jr CR, Wang RY (1996). Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24: 349-394.
3. Baldessarini RJ, Tarsey D (1980). Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Ann Rev Neurosci 3: 23-41.
4. Bassareo V, Di Chiara G (1999). Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89: 637-641.
5. Blackburn TP, Minabe Y, Middlemiss DN, Shirayama Y, Hashimoto K, Ashby Jr CR (2002). Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study. Synapse 46: 129-139.
6. Bromidge SM, Dabbs S, Davies DT, Davies S, Duckworth DM, Forbes IT et al (2000). Biarylcarbomolindones are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[92-methyl-3-pyridyl0oxyl-5-pyridyl] carbamoyl]-6-trifluoromethylindone (SB-243213) as a potential antidepressant/anxiolytic agent. J Med Chem 43: 1123-1134.
7. Bunney BS, Grace AA (1978). Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23: 1715-1728.
8. Casey DE (1991). Neuroleptic drug induced extrapyramindal syndromes and tardive dyskinesia. Schizophr Res 4: 109-121.
9. Chen J, Paredes W, Gardner EL (1991). Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured in vivo by brain microdialysis: further evidence for depolarization block. Neurosci Lett 122: 127-131.
10. Chiodo LA, Bunney BS (1983). Typical and atypical antipsychotics: differential effects of chronic administration the activity of A9 and A10 midbrain dopaminergic neurones. J Neurosci 3: 1607-1619.
11. Deutch AY (1996). Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. In: Csernansky JG (ed). Antipsychotics, Handbook of Experimental Pharmacology. Springer: Berlin, 120 pp 117-161.
12. Deutch AY, Cameron DS (1992). Pharmacological characterisation of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46: 49-56.
13. 3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurones. J Pharmacol Exp Ther 287: 51-57.
14. Di Matteo V, Cacchio M, Di Giulio C, Di Giovanni G, Esposito E (2002a). Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT2C receptors in vivo. Pharmacol Biochem Behav 71: 607-613.
15. Di Matteo V, Cacchio M, Di Giulio C, Esposito E (2002b). Role of serotonin2C receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav 71: 727-734.
16. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet M-F (1997). Pattern of expression of the serotonergic2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384: 233-247.
17. Goldstein JM, Litwin LC, Sutton EB, Malick JB (1993). Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 112: 293-298.
18. Gonon F (1988). Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurones as studied by in vivo electrochemistry. Neuroscience 24: 19-28.
19. Grace AA (1992). The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Trans (Suppl) 36: 91-131.
20. Grace AA, Bunney BS, Moore H, Todd CL (1997). Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20: 31-37.
21. Hedou G, Feldon J, Heidbreder CA (1999). Effects of cocaine on dopamine in sub-regions of the rat prefrontal cortex and their efferents to subterritories of the nucleus accumbens. Eur J Pharmacol 372: 143-155.
22. Heidbreder CA, Hedou G, Feldon J (1999). Behavioural neurochemistry reveals a new functional dichotomy in the shell subregion of the nucleus accumbens. Prog Neuro-Psychopharmacol Biol Psychiatry 23: 99-132.
23. Hernandez L, Hoebel BG (1995). Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens and striatal microdialysis in freely moving rats. Psychopharmacol Biochem Behav 52: 581-589.
24. Herrick-Davis K, Grinde E, Teitler M (2000). Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J Pharmacol Exp Therap 295: 226-232.
25. Horger BA, Elsworth JD, Roth RW (1995). Selective increase in dopamine utilisation in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. J Neurochem 65: 770-774.
26. Hurley MJ, Stubbs CM, Jenner P, Marsden CD (1996). Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR-103691 with typical and atypical neuroleptics. Eur J Pharmacol 318: 283-293.
27. Ichikawa J, Meltzer HY (1990). The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studies by in vivo microdialysis. Eur J Pharmacol 176: 371-374.
28. Invernizzi R, Pozzi R, Samanin R (1995). Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious animals. Brain Res 670: 165-168.
29. Kalivas PW, Duffy P (1995). Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675: 325-328.
30. King D, Zigmond MJ, Finlay JM (1997). Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience 77: 141-153.
31. Marcus MM, Nomikos GG, Svensson TH (1996). Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens. Eur Neuropsychopharmacol 6: 29-39.
32. Marcus MM, Nomikos GG, Svensson TH (2000). Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: role of 5-HT2A and α1-adrenoceptor antagonism. Eur Neuropsychopharmacol 10: 245-253.
33. Merchant KM, Dorsa DM (1993). Differential induction of C-Fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci USA 90: 3447-3451.
34. Meredith GE, Agolia R, Arts MPM, Groenewegen HJ, Zahm DS (1992). Morphological differences between projection neurons of the core and shell in the nucleus accumbens of the rat. Neuroscience 50: 149-162.
35. Moore H, Todd CL, Grace A (1998). Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurones. J Neurosci 18: 5068-5077.
36. Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson T (1994). Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopaminerggic release in the rat medial prefrontal cortex. Psychopharmacology 115: 147-156.
37. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Academic Press: London.
38. Pazos A, Palacios JM (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain: I. Serotonin-1 receptors. Brain Res 346: 205-230.
39. Pontieri FE, Tanda G, Di Chiara G (1995). Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc Natl Acad Sci USA 92: 12304-12308.
40. Rebec GV (1998). Real-time assessments of dopamine function during behaviour: single-unit recording, iontophoresis, and fast-scan cyclic voltammetry in awake, unrestrained rats. Alcohol Clin Exp Res 22: 32-40.
41. Rebec GV, Christensen JR, Guerra C, Bardo MT (1997). Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res 776: 61-67.
42. Skarsfeldt T (1988). Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats. Life Sci 42: 1037-1044.
43. Stockton ME, Rasmussen K (1996). Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14: 97-104.
44. Werme M, Ringholm A, Olson L, Brené S (2000). Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal sub-regions by haloperidol and clozapine. Brain Res 863: 112-119.
45. White FJ, Wang RY (1983). Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurones. Science 225: 1054-1057.
46. Wood MD, Reavul C, Trail B, Wilson A, Stean T, Kennett GA et al (2001). SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41: 186-199.
47. Zahm DS (2000). An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 24: 85-105.